Delivery technologies

15 Results

How to reduce crosslinking and ensure fast dissolution in soft caps

Recorded the 24-Apr-2024 | Webinar

Crosslinking is a natural phenomenon occurring in gelatin that negatively impacts soft capsules, reducing their stability and prolonging their dissolution...

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

In Vivo Evaluation of a Gastro-Resistant HPMC-Based “Next Generation Enteric” Capsule

Content provided by Lonza Capsules & Health Ingredients | 01-Sep-2023 | White Paper

Invivo: Many orally dosed APIs are bioavailable only when formulated as an enteric dosage form to protect them from the harsh environment of the stomach....

ReciBioPharm - An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization

Recipharm AB | Recorded the 14-Sep-2023 | Webinar

Assessing key parameters of the upstream process to achieve high titer while maintaining desired integrity
Customizing the downstream process to...

APAC Region Distribution Considerations for Clinical Trial Supplies

Content provided by Catalent | 19-Oct-2021 | Insight Guide

The Asia-Pacific (APAC) region has been a steadily growing area for sponsors to conduct clinical studies. Maintaining continuity of trial supply across...

A Better Approach, for Better Pain Trials

Content provided by Signant Health | 27-Sep-2021 | White Paper

Pain studies face unique challenges. For one, pain severity can only be truly assessed by the patients themselves. The controlled substances that are often...

Unlocking the Power and Versatility of Plant-Based Softgels

Content provided by Sofgen Pharmaceuticals | 23-Mar-2021 | Product Brochure

While plant-based diets continue to grow in popularity, the desire to live and act more sustainably and healthfully is on the rise.

Is clinical development prepared for the paradigm shift caused by COVID-19?

Content provided by Oracle Health Sciences | 15-Dec-2020 | Research Study

The COVID-19 pandemic has – without warning – turned clinical operations on its head, forcing the clinical research community to re-evaluate how to manage...

The impact of PAT tools for aseptic manufacturing processes

Content provided by Telstar Life Science Solutions | 29-Jun-2020 | Case Study

Telstar case study. What is the impact of leading-edge innovative developments on the process analytical technology field for pharmaceutical systems and...

Flow Cytometry Services

Content provided by Q² Solutions | 01-Jun-2020 | Infographic

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Local lab Data Management

Content provided by Q² Solutions | 01-May-2020 | Infographic

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

How to get reproducible DNA amplification

Content provided by Eppendorf Bioprocess Solutions | 27-Jun-2017 | Infographic

DNA concentration, mastermix preparation, temperature management: Doing PCR like a pro can be more complex than it seems.The Eppendorf infographic helps...

UPLC Analysis of Methoxy & 2-Hydroxypropoxy in Hypromellose

Content provided by SGS Life Science Services | 22-Feb-2016 | White Paper

Because of its use in the pharmaceutical and food industries, the USP has established standards relating to the amount of methoxyl and 2-hydroxypropoxyl...

Article on Viral Clearance for Biopharmaceuticals

Content provided by Catalent | 24-Aug-2015 | White Paper

Viral clearance studies are mandated prior to entering clinical trials and for commercial launch of biopharmaceuticals. These studies are a key component...

Customized Biosimilarity Analytical Testing from Catalent

Content provided by Catalent | 26-Jan-2015 | White Paper

Assessment of biosimilar molecules requires an orthogonal analytical approach. Any one particular analytical technique is not able to fully define the...